status: 200
content-location: http://rest.kegg.jp/get/path:map05202
server: Apache
date: Wed, 15 Oct 2014 14:59:06 GMT
content-type: text/plain

ENTRY       map05202                    Pathway
NAME        Transcriptional misregulation in cancer
CLASS       Human Diseases; Cancers
PATHWAY_MAP map05202  Transcriptional misregulation in cancer
DISEASE     H00001  Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
            H00002  Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
            H00003  Acute myeloid leukemia (AML)
            H00006  Hairy-cell leukemia
            H00007  Hodgkin lymphoma
            H00010  Multiple myeloma
            H00011  Lymphoplasmacytic lymphoma
            H00021  Renal cell carcinoma
            H00024  Prostate cancer
            H00032  Thyroid cancer
            H00034  Carcinoid
            H00035  Ewing's sarcoma
            H00037  Alveolar rhabdomyosarcoma
            H00043  Neuroblastoma
            H00049  Myxoid liposarcoma
            H00050  Synovial sarcoma
            H00051  Alveolar soft part sarcoma
            H00052  Clear cell sarcoma of soft tissue
            H00053  Extraskeletal myxoid chondrosarcoma
            H01102  Pituitary adenomas
REFERENCE   PMID:11607818
  AUTHORS   Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M, Pelicci PG
  TITLE     Common themes in the pathogenesis of acute myeloid leukemia.
  JOURNAL   Oncogene 20:5680-94 (2001)
REFERENCE   PMID:12032780
  AUTHORS   Scandura JM, Boccuni P, Cammenga J, Nimer SD
  TITLE     Transcription factor fusions in acute leukemia: variations on a theme.
  JOURNAL   Oncogene 21:3422-44 (2002)
REFERENCE   PMID:12529654
  AUTHORS   Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C
  TITLE     New mechanisms of AML1 gene alteration in hematological malignancies.
  JOURNAL   Leukemia 17:9-16 (2003)
REFERENCE   PMID:10717473
  AUTHORS   Lutterbach B, Hiebert SW
  TITLE     Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation.
  JOURNAL   Gene 245:223-35 (2000)
REFERENCE   PMID:19075268
  AUTHORS   Koschmieder S, Halmos B, Levantini E, Tenen DG
  TITLE     Dysregulation of the C/EBPalpha differentiation pathway in human cancer.
  JOURNAL   J Clin Oncol 27:619-28 (2009)
REFERENCE   PMID:11340171
  AUTHORS   Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR, Tenen DG
  TITLE     c-Myc is a critical target for c/EBPalpha in granulopoiesis.
  JOURNAL   Mol Cell Biol 21:3789-806 (2001)
REFERENCE   PMID:15985538
  AUTHORS   Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP
  TITLE     Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in  myeloid leukemia.
  JOURNAL   Blood 106:2827-36 (2005)
REFERENCE   PMID:12393465
  AUTHORS   Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G
  TITLE     The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
  JOURNAL   Blood 101:270-7 (2003)
REFERENCE   PMID:12130514
  AUTHORS   Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG
  TITLE     Heterozygous PU.1 mutations are associated with acute myeloid leukemia.
  JOURNAL   Blood 100:998-1007 (2002)
REFERENCE   PMID:15160934
  AUTHORS   Jing Y
  TITLE     The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
  JOURNAL   Leuk Lymphoma 45:639-48 (2004)
REFERENCE   PMID:15024077
  AUTHORS   Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Kohler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H
  TITLE     Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
  JOURNAL   Mol Cell Biol 24:2890-904 (2004)
REFERENCE   PMID:19855079
  AUTHORS   Rice KL, Hormaeche I, Doulatov S, Flatow JM, Grimwade D, Mills KI, Leiva M, Ablain J, Ambardekar C, McConnell MJ, Dick JE, Licht JD
  TITLE     Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.
  JOURNAL   Blood 114:5499-511 (2009)
REFERENCE   PMID:10500199
  AUTHORS   McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C
  TITLE     Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia.
  JOURNAL   Proc Natl Acad Sci U S A 96:11464-9 (1999)
REFERENCE   PMID:15156184
  AUTHORS   Zelent A, Greaves M, Enver T
  TITLE     Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.
  JOURNAL   Oncogene 23:4275-83 (2004)
REFERENCE   PMID:14630078
  AUTHORS   Sawinska M, Ladon D
  TITLE     Mechanism, detection and clinical significance of the reciprocal translocation t(12;21)(p12;q22) in the children suffering from acute lymphoblastic leukaemia.
  JOURNAL   Leuk Res 28:35-42 (2004)
REFERENCE   PMID:19141473
  AUTHORS   Guenther MG, Lawton LN, Rozovskaia T, Frampton GM, Levine SS, Volkert TL, Croce CM, Nakamura T, Canaani E, Young RA
  TITLE     Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage  leukemia.
  JOURNAL   Genes Dev 22:3403-8 (2008)
REFERENCE   PMID:16169901
  AUTHORS   Xia ZB, Popovic R, Chen J, Theisler C, Stuart T, Santillan DA, Erfurth F, Diaz MO, Zeleznik-Le NJ
  TITLE     The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B  (p27kip1) expression.
  JOURNAL   Proc Natl Acad Sci U S A 102:14028-33 (2005)
REFERENCE   PMID:21518926
  AUTHORS   Wang QF, Wu G, Mi S, He F, Wu J, Dong J, Luo RT, Mattison R, Kaberlein JJ, Prabhakar S, Ji H, Thirman MJ
  TITLE     MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
  JOURNAL   Blood 117:6895-905 (2011)
REFERENCE   PMID:14701735
  AUTHORS   Zeisig BB, Milne T, Garcia-Cuellar MP, Schreiner S, Martin ME, Fuchs U, Borkhardt A, Chanda SK, Walker J, Soden R, Hess JL, Slany RK
  TITLE     Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
  JOURNAL   Mol Cell Biol 24:617-28 (2004)
REFERENCE   PMID:19133982
  AUTHORS   Riz I, Hawley TS, Johnston H, Hawley RG
  TITLE     Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.
  JOURNAL   Br J Haematol 145:140-3 (2009)
REFERENCE   PMID:12511414
  AUTHORS   Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R, Mooller P
  TITLE     Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.
  JOURNAL   Blood 101:3681-6 (2003)
REFERENCE   PMID:11313274
  AUTHORS   Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C
  TITLE     Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.
  JOURNAL   Blood 97:2798-807 (2001)
REFERENCE   PMID:12670461
  AUTHORS   Zuzel M, Cawley JC.
  TITLE     The biology of hairy cells.
  JOURNAL   Best Pract Res Clin Haematol 16:1-13 (2003)
REFERENCE   PMID:14998494
  AUTHORS   Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM
  TITLE     Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.
  JOURNAL   Cancer Cell 5:191-9 (2004)
REFERENCE   PMID:20974671
  AUTHORS   Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, Levens DL, Kelleher NL, Licht JD
  TITLE     The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
  JOURNAL   Blood 117:211-20 (2011)
REFERENCE   PMID:19059936
  AUTHORS   Brito JL, Walker B, Jenner M, Dickens NJ, Brown NJ, Ross FM, Avramidou A, Irving JA, Gonzalez D, Davies FE, Morgan GJ
  TITLE     MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.
  JOURNAL   Haematologica 94:78-86 (2009)
REFERENCE   PMID:10350329
  AUTHORS   Iida S, Rao PH, Ueda R, Chaganti RS, Dalla-Favera R
  TITLE     Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).
  JOURNAL   Leuk Lymphoma 34:25-33 (1999)
REFERENCE   PMID:10784387
  AUTHORS   Ohno H, Ueda C, Akasaka T
  TITLE     The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
  JOURNAL   Leuk Lymphoma 36:435-45 (2000)
REFERENCE   PMID:19233641
  AUTHORS   Prensner JR, Chinnaiyan AM
  TITLE     Oncogenic gene fusions in epithelial carcinomas.
  JOURNAL   Curr Opin Genet Dev 19:82-91 (2009)
REFERENCE   PMID:19406209
  AUTHORS   Brenner JC, Chinnaiyan AM
  TITLE     Translocations in epithelial cancers.
  JOURNAL   Biochim Biophys Acta 1796:201-15 (2009)
REFERENCE   PMID:16946003
  AUTHORS   Reddi HV, McIver B, Grebe SK, Eberhardt NL.
  TITLE     THE PAX8/PPAR{gamma} ONCOGENE IN THYROID TUMORIGENESIS.
  JOURNAL   Endocrinology : (2006)
REFERENCE   PMID:19422821
  AUTHORS   Medendorp K, van Groningen JJ, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, van Kessel AG
  TITLE     The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.
  JOURNAL   Exp Cell Res 315:2399-409 (2009)
REFERENCE   PMID:18563191
  AUTHORS   Kumar-Sinha C, Tomlins SA, Chinnaiyan AM
  TITLE     Recurrent gene fusions in prostate cancer.
  JOURNAL   Nat Rev Cancer 8:497-511 (2008)
REFERENCE   PMID:20478527
  AUTHORS   Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM
  TITLE     An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.
  JOURNAL   Cancer Cell 17:443-54 (2010)
REFERENCE   PMID:21747944
  AUTHORS   Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R
  TITLE     TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.
  JOURNAL   PLoS One 6:e21650 (2011)
REFERENCE   PMID:17505060
  AUTHORS   Cai C, Hsieh CL, Omwancha J, Zheng Z, Chen SY, Baert JL, Shemshedini L
  TITLE     ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.
  JOURNAL   Mol Endocrinol 21:1835-46 (2007)
REFERENCE   PMID:18172298
  AUTHORS   Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM
  TITLE     Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
  JOURNAL   Cancer Res 68:73-80 (2008)
REFERENCE   PMID:21849159
  AUTHORS   Westermark UK, Wilhelm M, Frenzel A, Henriksson MA
  TITLE     The MYCN oncogene and differentiation in neuroblastoma.
  JOURNAL   Semin Cancer Biol 21:256-66 (2011)
REFERENCE   PMID:20153925
  AUTHORS   Bell E, Chen L, Liu T, Marshall GM, Lunec J, Tweddle DA
  TITLE     MYCN oncoprotein targets and their therapeutic potential.
  JOURNAL   Cancer Lett 293:144-57 (2010)
REFERENCE   PMID:15644444
  AUTHORS   Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A, Shohet JM
  TITLE     The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
  JOURNAL   Proc Natl Acad Sci U S A 102:731-6 (2005)
REFERENCE   PMID:20190806
  AUTHORS   Ochiai H, Takenobu H, Nakagawa A, Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H, Kohno Y, Nakagawara A, Kamijo T
  TITLE     Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
  JOURNAL   Oncogene 29:2681-90 (2010)
REFERENCE   PMID:20145147
  AUTHORS   Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA
  TITLE     p53 is a direct transcriptional target of MYCN in neuroblastoma.
  JOURNAL   Cancer Res 70:1377-88 (2010)
REFERENCE   PMID:17327229
  AUTHORS   Beierle EA, Trujillo A, Nagaram A, Kurenova EV, Finch R, Ma X, Vella J, Cance WG, Golubovskaya VM
  TITLE     N-MYC regulates focal adhesion kinase expression in human neuroblastoma.
  JOURNAL   J Biol Chem 282:12503-16 (2007)
REFERENCE   PMID:21123453
  AUTHORS   Iraci N, Diolaiti D, Papa A, Porro A, Valli E, Gherardi S, Herold S, Eilers M, Bernardoni R, Della Valle G, Perini G
  TITLE     A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.
  JOURNAL   Cancer Res 71:404-12 (2011)
REFERENCE   PMID:17024155
  AUTHORS   Dreijerink KM, Hoppener JW, Timmers HM, Lips CJ
  TITLE     Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
  JOURNAL   Nat Clin Pract Endocrinol Metab 2:562-70 (2006)
REFERENCE   PMID:19075677
  AUTHORS   Wu X, Hua X
  TITLE     Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  JOURNAL   Curr Mol Med 8:805-15 (2008)
REFERENCE   PMID:19564705
  AUTHORS   Sakurai A, Murakami A, Sano K, Uchino S, Fukushima Y
  TITLE     Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.
  JOURNAL   Endocr J 56:887-95 (2009)
REFERENCE   PMID:17222504
  AUTHORS   Yang Y, Hua X
  TITLE     In search of tumor suppressing functions of menin.
  JOURNAL   Mol Cell Endocrinol 265-266:34-41 (2007)
REFERENCE   PMID:15826838
  AUTHORS   Aman P
  TITLE     Fusion oncogenes in tumor development.
  JOURNAL   Semin Cancer Biol 15:236-43 (2005)
REFERENCE   PMID:12527902
  AUTHORS   Fukuma M, Okita H, Hata J, Umezawa A
  TITLE     Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
  JOURNAL   Oncogene 22:1-9 (2003)
REFERENCE   PMID:18648544
  AUTHORS   Cironi L, Riggi N, Provero P, Wolf N, Suva ML, Suva D, Kindler V, Stamenkovic I
  TITLE     IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.
  JOURNAL   PLoS One 3:e2634 (2008)
REFERENCE   PMID:17250957
  AUTHORS   Riggi N, Stamenkovic I.
  TITLE     The Biology of Ewing sarcoma.
  JOURNAL   Cancer Lett 254:1-10 (2007)
REFERENCE   PMID:20490326
  AUTHORS   Jedlicka P
  TITLE     Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.
  JOURNAL   Int J Clin Exp Pathol 3:338-47 (2010)
REFERENCE   PMID:19738075
  AUTHORS   Ordonez JL, Osuna D, Herrero D, de Alava E, Madoz-Gurpide J
  TITLE     Advances in Ewing's sarcoma research: where are we now and what lies ahead?
  JOURNAL   Cancer Res 69:7140-50 (2009)
REFERENCE   PMID:12527906
  AUTHORS   Jishage M, Fujino T, Yamazaki Y, Kuroda H, Nakamura T
  TITLE     Identification of target genes for EWS/ATF-1 chimeric transcription factor.
  JOURNAL   Oncogene 22:41-9 (2003)
REFERENCE   PMID:15826834
  AUTHORS   Gerald WL, Haber DA
  TITLE     The EWS-WT1 gene fusion in desmoplastic small round cell tumor.
  JOURNAL   Semin Cancer Biol 15:197-205 (2005)
REFERENCE   PMID:18855877
  AUTHORS   Filion C, Motoi T, Olshen AB, Lae M, Emnett RJ, Gutmann DH, Perry A, Ladanyi M, Labelle Y
  TITLE     The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
  JOURNAL   J Pathol 217:83-93 (2009)
REFERENCE   PMID:18330902
  AUTHORS   Kim S, Lee HJ, Jun HJ, Kim J
  TITLE     The hTAF II 68-TEC fusion protein functions as a strong transcriptional activator.
  JOURNAL   Int J Cancer 122:2446-53 (2008)
REFERENCE   PMID:10537274
  AUTHORS   Sjogren H, Meis-Kindblom J, Kindblom LG, Aman P, Stenman G
  TITLE     Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.
  JOURNAL   Cancer Res 59:5064-7 (1999)
REFERENCE   PMID:15688424
  AUTHORS   Goransson M, Elias E, Stahlberg A, Olofsson A, Andersson C, Aman P
  TITLE     Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.
  JOURNAL   Int J Cancer 115:556-60 (2005)
REFERENCE   PMID:18850010
  AUTHORS   Goransson M, Andersson MK, Forni C, Stahlberg A, Andersson C, Olofsson A, Mantovani R, Aman P
  TITLE     The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target  genes by interaction with NFKBIZ.
  JOURNAL   Oncogene 28:270-8 (2009)
REFERENCE   PMID:20863376
  AUTHORS   Willems SM, Schrage YM, Bruijn IH, Szuhai K, Hogendoorn PC, Bovee JV
  TITLE     Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity  and casein kinase II inhibition as a potential treatment option.
  JOURNAL   Mol Cancer 9:257 (2010)
REFERENCE   PMID:18457914
  AUTHORS   Linardic CM
  TITLE     PAX3-FOXO1 fusion gene in rhabdomyosarcoma.
  JOURNAL   Cancer Lett 270:10-8 (2008)
REFERENCE   PMID:11863357
  AUTHORS   Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB
  TITLE     Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.
  JOURNAL   Genomics 79:278-84 (2002)
REFERENCE   PMID:17101797
  AUTHORS   Ishida M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, Yokozeki H, Nishioka K, Matsukage A, Ohki M, Ohta T
  TITLE     The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma.
  JOURNAL   Mol Cell Biol 27:1348-55 (2007)
REFERENCE   PMID:19472090
  AUTHORS   Jun HJ, Lee J, Lim do H, Park JO, Ahn G, Seo SW, Sung KS, Lim do H, Yoo KH, Choi YL
  TITLE     Expression of MET in alveolar soft part sarcoma.
  JOURNAL   Med Oncol 27:459-65 (2010)
REFERENCE   PMID:21779514
  AUTHORS   Rivlin N, Brosh R, Oren M, Rotter V
  TITLE     Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.
  JOURNAL   Genes Cancer 2:466-74 (2011)
REFERENCE   PMID:21765642
  AUTHORS   Suzuki K, Matsubara H
  TITLE     Recent advances in p53 research and cancer treatment.
  JOURNAL   J Biomed Biotechnol 2011:978312 (2011)
KO_PATHWAY  ko05202
///
